Recent Updates
Recently added Catalysts
EBS

Emergent BioSolutions to Participate in Investor Conferences

Key Takeaway: GAITHERSBURG, Md., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following investor conferences during the first quarter of 2020: 38th Annual J.P. Morgan He

Full Press Release Details

GAITHERSBURG, Md., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following investor conferences during the first quarter of 2020:
38th Annual J.P. Morgan Healthcare Conference
January 13 to 16, 2020
Company presentation scheduled on January 14 at 10:30am PST/1:30pm EST
Cowen 40th Annual Health Care Conference
March 2 to March 4, 2020
Presentation date and time will be updated on the Emergent website as the information becomes available.
For these conferences, the company will be webcasting its presentations, which may include a discussion of the company's recent business developments as well as its financial results and guidance. The webcasts will be available both live and by replay, accessible from the Emergent website www.emergentbiosolutions.com under “Investors.”
About Emergent BioSolutions
Vice President, Investor Relations
Vice President, Corporate Communications

Tags

Emergent Investor Conferences
Investor Conferences
EBS JP Morgan Healthcare
Last updated: Jan 6, 2020